Company: BLZRW
Filing Date: 2025-08-25
Form Type: S-1/A
Source: 0001213900-25-080183
Chunk: 9

Company: Trailblazer Acquisition Corp.
Filing Date: 2025-08-25
Form: S-1/A
Chunk 9
---
 commissions |     | $        |  0.60 |     | $     |  12,000,000 |
| Proceeds, before expenses, to us       |     | $        |  9.40 |     | $     | 188,000,000 |

____________ (1)Includes $0.20 per unit (excluding any units sold pursuant to the underwriters’ option to purchase additional units), or $4,000,000 in the aggregate (whether or not the underwriters’ option to purchase additional units is exercised), payable to Cantor Fitzgerald & Co. upon the closing of this offering. Also includes $0.40 per unit on units other than those sold pursuant to the underwriters’ option to purchase additional units and $0.60 per unit on units sold pursuant to the underwriters’ option to purchase additional units, or $8,000,000 in the aggregate or up to $9,800,000 in the aggregate if the underwriters’ over -allotmentoption is exercised in full, payable to Cantor Fitzgerald & Co. for deferred underwriting commissions to be deposited into a trust account located in the United States and released to Cantor Fitzgerald & Co. for its own account only upon the completion of an initial business combination. See also “Underwriting” for a description of compensation and other items of value payable to the underwriters. Of the proceeds we receive from this offering and the sale of the private placement warrants described in this prospectus, $200 million, or $230 million if the underwriters’ overallotment option is exercised in full ($10.00 per unit in either case), will be placed into a U.S. -basedtrust account with Continental Stock Transfer & Trust Company acting as trustee. The following table illustrates the difference between the public offering price per unit and our net tangible book value per share (NTBV), as adjusted to give effect to this offering and assuming the redemption of our public shares at varying levels and the exercise in full and no exercise of the over -allotmentoption. See section entitled “Dilution” on page 95 for more information.

| As of June 30, 2025 |                                                 |     |                |      |     |            |      |     |                |      |     |            |      |     |                |      |     |            |      |     |            |       |     |            |       |
|:--------------------|------------------------------------------------:|:----|:---------------|-----